Aspira Women's Health Inc Sustainability Reports
Aspira Women's Health Inc. discovers, develops, and commercializes innovative diagnostic tests and bio-analytical tools for gynecologic diseases. Its primary products include FDA-cleared blood tests for evaluating ovarian cancer risk in women with adnexal masses.
Sector: Healthcare & social services
Country: United States
Exchange: OTC Markets
LEI: 54930045CGQ3XUO9T533
2 reports from 2022 to 2023
